Back
Lineage Cell Therapeutics, Inc. Stock Predictions
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now
Sell
36
LCTX
Lineage Cell Therapeutics, Inc.
Last Price:
$1.71
Seasonality Move:
11.05%
7 Day Trial
ALL ACCESS PASS
$
7
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist NowLineage Cell Therapeutics, Inc. Stock Forecast
-
Is Lineage Cell Therapeutics, Inc. Stock Undervalued?The current Lineage Cell Therapeutics, Inc. [LCTX] share price is $1.72. The Score for LCTX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
LCTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Lineage Cell Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Lineage Cell Therapeutics, Inc. Stock Rating
Data Unavailable
Lineage Cell Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lineagecell.com
52-Week Data
52-Week High:
2.09
52-Week Low:
0.37
Prediction Charts
Market Cap:
396.2M
Price in USD:
1.72
Volume:
854K
Beta:
1.31
Technical Analysis
SMA50:
1.74
SMA100:
1.47
SMA200:
1.04
52-Wk Change:
201.12%
Stock Predictions
-
Is Lineage Cell Therapeutics, Inc. stock public?Yes, Lineage Cell Therapeutics, Inc. is a publicly traded company.
-
What is the Lineage Cell Therapeutics, Inc. stock quote today?The Lineage Cell Therapeutics, Inc. stock price is 1.72 USD today.
-
How to buy Lineage Cell Therapeutics, Inc. stock online?You can buy Lineage Cell Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 1.90 | 1.74 | 1.90 | 1.74 |
| Nov-18 | 1.72 | 1.77 | 1.78 | 1.70 |
| Nov-19 | 1.75 | 1.71 | 1.78 | 1.68 |
| Nov-20 | 1.70 | 1.67 | 1.78 | 1.66 |
| Nov-21 | 1.71 | 1.74 | 1.75 | 1.67 |
| Nov-24 | 1.76 | 1.75 | 1.81 | 1.69 |
| Nov-25 | 1.77 | 1.74 | 1.81 | 1.71 |
| Nov-26 | 1.75 | 1.71 | 1.75 | 1.69 |
| Nov-28 | 1.71 | 1.76 | 1.76 | 1.69 |
| Dec-1 | 1.73 | 1.66 | 1.76 | 1.64 |
| Dec-2 | 1.66 | 1.61 | 1.68 | 1.58 |
| Dec-3 | 1.62 | 1.68 | 1.71 | 1.57 |
| Dec-4 | 1.65 | 1.74 | 1.75 | 1.62 |
| Dec-5 | 1.74 | 1.72 | 1.75 | 1.70 |
Lineage Cell Therapeutics, Inc. Earnings
Data Unavailable
Lineage Cell Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.23 per share.
* Lineage Cell Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.